J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 581, Number 3, 1001-1018, June 15, 2007 DOI: 10.1113/jphysiol.2007.132886
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
581/3/1001    most recent
jphysiol.2007.132886v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadley, S. H.
Right arrow Articles by Amin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadley, S. H.
Right arrow Articles by Amin, J.
Related Collections
Right arrow Neuroscience

NEUROSCIENCE

Rat {alpha}6beta2{delta} GABAA receptors exhibit two distinct and separable agonist affinities

Stephen H. Hadley1 and Jahanshah Amin1

1 Department of Molecular pharmacology and physiology, College of Medicine, University of South Florida, Tampa, FL, 33612-4799, USA


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The onset of motor learning in rats coincides with exclusive expression of GABAA receptors containing {alpha}6 and {delta} subunits in the granule neurons of the cerebellum. This development temporally correlates with the presence of a spontaneously active chloride current through {alpha}6-containing GABAA receptors, known as tonic inhibition. Here we report that the coexpression of {alpha}6, beta2, and {delta} subunits produced receptor–channels which possessed two distinct and separable states of agonist affinity, one exhibiting micromolar and the other nanomolar affinities for GABA. The high-affinity state was associated with a significant level of spontaneous channel activity. Increasing the level of expression or the ratio of beta2 to {alpha}6 and {delta} subunits increased the prevalence of the high-affinity state. Comparative studies of {alpha}6beta2{delta}, {alpha}1beta2{delta}, {alpha}6beta2{gamma}2, {alpha}1beta2{gamma}2 and {alpha}4beta2{delta} receptors under equivalent levels of expression demonstrated that the significant level of spontaneous channel activity is uniquely attributable to {alpha}6beta2{delta} receptors. The pharmacology of spontaneous channel activity arising from {alpha}6beta2{delta} receptor expression corresponded to that of tonic inhibition. For example, GABAA receptor antagonists, including furosemide, blocked the spontaneous current. Further, the neuroactive steroid 5{alpha}-THDOC and classical glycine receptor agonists beta-alanine and taurine directly activated {alpha}6beta2{delta} receptors with high potency. Specific mutation within the GABA-dependent activation domain (betaY157F) impaired both low- and high-affinity components of GABA agonist activity in {alpha}6betaY157F{delta} receptors, but did not attenuate the spontaneous current. In comparison, a mutation located between the second and third transmembrane segments of the {delta} subunit ({delta}R287M) significantly diminished the nanomolar component and the spontaneous activity. The possibility that the high affinity state of the {alpha}6beta2{delta} receptor modulates the granule neuron activity as well as potential mechanisms affecting its expression are discussed.

(Received 26 March 2007; accepted after revision 28 March 2007; first published online 29 March 2007)
Corresponding author J. Amin: University of South Florida, College of Medicine, Department of Pharmacology and Therapeutics, MDC box 9, 12901 Bruce B. Downs Blvd. Tampa, FL 33612, USA. Email: jamin{at}health.usf.edu


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Ligand-gated ion channels comprise a large family of membrane-embedded receptors which play a central role in neuronal transmission. The binding of a neurotransmitter to the receptor domain of this class of membrane proteins opens an integrated ion channel, allowing selected ions to permeate. Such receptor–channels are either excitatory or inhibitory in nature, modulating the frequency of action potential initiation. The most widely expressed inhibitory class of ligand-gated ion channels are {gamma}-aminobutyric acid type A (GABAA) receptors. Assembled from a diverse range of subunits termed {alpha}(1-6),beta(1-3), {gamma}(1-3), {delta}, {pi} and {varepsilon}, each subtype of GABAA receptor exhibits unique kinetics, agonist affinity and pharmacology (Hevers & Luddens, 1998; Sieghart & Sperk, 2002; Wallner et al. 2003; Hanchar et al. 2005).

Cerebellar granule neurons are central to the control of information flow through the cerebellar cortex and are postulated to play a fundamental role in motor learning activity (Marr, 1969; Tyrrell & Willshaw, 1992; Thompson & Stephenson, 1994; Mellor et al. 1998). These neurons evince unique anatomical characteristics and GABAA subunit expression that temporally coincide with the learning and development of motor skills. During the first postnatal week in rats, granule cells start migrating towards the inner granule layer, where they progressively begin to express both {alpha}6 and {delta} GABAA subunits (Laurie et al. 1992; Persohn et al. 1992; Wisden et al. 1996). The {alpha}6 subunit mRNA becomes detectable approximately 1 week after birth and is followed by the {alpha}6-dependent expression of the {delta} subunit (Laurie et al. 1992; Jones et al. 1997; Nusser et al. 1999). The expression of {alpha}6 and {delta} subunits gradually increases throughout postnatal development, reaching their highest levels in adulthood (Laurie et al. 1992; Persohn et al. 1992; Jechlinger et al. 1998). This exclusive expression paradigm makes receptors containing {alpha}6 and {delta} subunits the predominant GABAA receptor subtype expressed within cerebellar granule neurons in adulthood (Quirk et al. 1994; Nusser et al. 1999; Tretter et al. 2001). The temporal expression of {alpha}6 and {delta} subunits within the granule neurons correlates with the development of a spontaneous chloride current known as tonic inhibition (Kaneda et al. 1995; Brickley et al. 1996; Wall & Usowicz, 1997; Hamann et al. 2002). The spillover or diffusion of GABA from synaptic events is thought to activate the {alpha}6-containing GABAA receptors resulting in a tonic inhibition (Isaacson et al. 1993; Rossi & Hamann, 1998; Hamann et al. 2002; Mody & Pearce, 2004; Semyanov et al. 2004; Farrant & Nusser, 2005). Studies in animal models are gradually establishing the importance of tonic inhibition in the regulation of motor activity (Thompson et al. 1998; Chiu et al. 2005). For example, GABA transporter type 1 (GAT1) knockout mice display various neuronal deficits, including tremor and ataxia, that may arise due to a significant increase in the level of tonic chloride conductance within the cerebellar granule neurons (Chiu et al. 2005).

To simulate the temporal coexpression of {alpha}6 and {delta} subunits within granule neurons, we investigated the characteristics of {alpha}6beta{delta} receptors under different levels and conditions of expression. The structure–function relationship of {alpha}6beta2{delta} receptors was further examined using mutations of conserved residues within the beta2 or {delta} subunit.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Oocyte preparation

The Xenopus laevis frogs were anaesthetized by bathing in a solution containing 0.1% MS222 (Tricaine methane sulphonate, Sigma-Alderich, St Louis, MO, USA). Before ovariectomy, the state of anaesthesia was assessed by pinching the toe of the frog. After surgery, the frog was killed by decapitation according to a protocol approved by the Institutional Animal Care and Use Committee. Oocytes were placed in a calcium-free oocyte Ringer solution (calcium-free OR2; 83.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 1 mM Na2HPO4 and 5 mM Hepes, pH 7.5) plus 0.3% collagenase A (Roche Applied Science, Indianapolis, IN, USA) for approximately 1 h. Stage V and VI oocytes were isolated and maintained by incubating in OR2 (82.5 mM NaCl, 1 mM CaCl2, 2.5 mM KCl, 1 mM MgCl2, 2 mM sodium pyruvate, 1 mM Na2HPO4, 50 U ml–1 penicillin, 50 U ml–1 streptomycin and 5 mM Hepes, pH 7.5) with 2% horse serum at 18°C.

Quantification of complementary RNAs (cRNA) and oocyte injections

The procedure for in vitro transcription of cRNA have been previously described (Walters et al. 2000). The quality of cRNA was determined by electrophoresis on a 1% formaldehyde-containing agarose gel. cRNA concentrations were measured spectrophotometrically. For most experiments, we tested two preparations of cRNAs for each subunit.

Micropipettes for injecting cRNA were fabricated using a Sutter P87 horizontal puller (Sutter Instruments Co., Novato, CA, USA) and, to ensure uniformity of size, the tip of each micropipette was cut with microscissors under 45x magnification next to a control-cut needle. Using a Picospritzer II (General Valve Corporation, Fairfield, NJ, USA), cRNA subunits reconstituted in diethylpyrocarbonate-treated water were injected into Xenopus laevis oocytes at a ratio of 1{alpha} : 1beta2 : 1.8({gamma}2 or {delta}). The cRNA combinations were injected in amounts of 1.5–3 ng, 5–7 ng, and 8–12 ng per oocyte to produce, respectively, low, intermediate and high levels of expression. For comparison of the different GABAA subtypes, we coinjected 5–7 ng of cRNA (intermediate expression level) for each combination ({alpha}6beta2{delta}, {alpha}1beta2{delta}, {alpha}6beta2{gamma}2, {alpha}1beta2{gamma}2 and {alpha}4beta2{delta}), using two sets of cRNA-mixture preparations and two batches of oocytes.

Drug preparations

Forusemide, bicuculline and picrotoxinin were purchased from Sigma-Alderich Corp. (St Louis, MO, USA). Allotetrahydrodeoxycorticosterone (5{alpha}-THODC) was obtained from Steraloids, Inc (Newport, RI, USA). Forusemide, bicuculline, picrotoxinin and 5{alpha}-THODC were dissolved in dimethylsulfoxide at their respective stock solution concentrations of 100, 40, 100 and 20 mM. The test solutions were made by diluting the stock solutions in the recording OR2 solution (mM: NaCl, 82.5; KCl, 2.5; Hepes, 5; CaCl2, 1; MgCl2, 1; pH 7.5). The highest concentration of the vehicle solution (0.5% of DMSO) did not significantly alter the level of {alpha}6beta2{delta} recptors activity.

Electrophysiology

Three to four days after injection, oocytes were placed on a mesh within a small perfusing volume chamber (~75 µl), with t1/2 and clearance times of approximately 3 and 10 s, respectively. For complete description of the drug application system see Walters et al. (2000).

We used a two-electrode voltage-clamp amplifier (Turbo TEC-05 npi, Adams and List, Westbury, NY, USA) to record currents in response to the application of drugs. Recording microelectrodes were fabricated with a Narishige PP-83 puller (Narishige, Japan) and filled with 3 M KCl. We used electrodes with input resistances of 0.7–1.6 M{Omega}. Membrane potential was clamped to –70 mV. Data were visualized on a TA-240 chart recorder (Gould Instrument System, Valley View, CA, USA) during the experiments and stored online using Pulse Fit.

Measurement of the spontaneous current and statistical analysis

High concentrations of GABA (mM) do not evoke a current in mock-injected oocytes indicating an absence of endogenous GABAA receptors. Upon impaling an oocyte with a pair of electrodes, the oocyte initially displayed a leak current (holding potential = –70 mV). This leak current did not reverse at –30 mV (the predicted reversal potential for chloride in oocytes under these conditions) and within 4–5 min reduced to < 30 nA. If waiting time following the impalement was longer (~10–15 min), the leak current would have gradually decreased to a value of a few nanoamps, suggesting that the initial random leak may result from an incomplete sealing of the membrane around the electrode. In experiments where the time allocated for recording from each oocyte were short (~4–5 min, due to large number of oocytes tested in one day), the averaged control leak current measured from the mock-injected oocytes was subtracted from the data and such corrections are noted in Results. However, in most experiments, the wait-time was more than 10 min and thus the mock-injected oocytes did not show any significant leak current. It is also important to note that spontaneous currents arising from {alpha}6beta2{delta} receptors (in most experiments) are at least an order of magnitude higher than any control leak current recorded (the range of averages of leak current in control cells in different experiments was 14–23 nA where the wait time before measurement was < 5 min).

The analysis of variance (ANOVA one-way) and Fisher's LSD multiple comparison test were used for statistical investigation. All statistical calculations are presented as means ± standard error of the mean.

Data analysis

The EC50 and Hill coefficients for the agonists were estimated by fitting the data from concentration–response relationships to the Hill equation according to the following formula (Sigma plot 2000 or Origin 6.0):


Formula 1

(1)
Alternatively, the data were fitted with a sum of two Hill equations (Origin, 6.0)


Formula 2

(2)
where I is the peak current at a given concentration of agonist (A), Imax is the maximum current, EC50 is the concentration of agonist yielding a half-maximal current, and nH is the Hill coefficient.

In the high or low expression condition for the wild-type {alpha}6beta2{delta} receptors, where one component dominates, the fit of the data points to the sum of two Hill equations using Origin software does not give a satisfactory result (confidence > 0.95). Even in cases when the fitting was successful, the obtained double fit for most low and high expression experiments did not closely follow the experimental data point obtained at high or low concentration ranges, respectively. We postulate that under low or high expression conditions, the apparent desensitization/inactivation of the high affinity component may hinder reliable fitting with the sum of two Hill equations.

To quantify the inhibitory effect of antagonists, the data were fitted to the following equation


Formula 3

(3)
where I is the peak current at a given concentration of antagonist (An), Imax is the level of spontaneous current in the absence of antagonist, IC50 is the concentration of antagonist inhibiting half of the spontaneous current, and nH is the slope.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
{alpha}6beta2{delta} receptors exhibit distinct agonist affinity states

cRNA of rat wild-type {alpha}6, beta2 and {delta} subunits (Bernard et al. 1998) was injected into Xenopus laevis oocytes in increments of 1.5–3, 5–7 and 8–12 ng per oocyte to produce low, intermediate and high levels of expression, respectively (at a ratio of 1{alpha}6 : 1beta2 : 1.8{delta}). Three to four days after injection, GABA-activated currents were recorded using a GABA concentration range from 0.0002 to 300 µM. Figure 1 shows the current traces and GABA concentration–response relationships for three representative oocytes with low, intermediate and high levels of expression of {alpha}6beta2{delta} receptors. At low expression levels (Fig. 1, filled circles; holding potential –70 mV), the GABA concentration–response relationship yielded an EC50 (a concentration eliciting half-maximal current) of 1.77 µM and a Hill coefficient (nH) of 0.49 (GABA maximal current; GABA Imax = 206 nA). At intermediate expression levels (Fig. 1, open circles), a spontaneous current became apparent (shaded area; 80 nA; GABA Imax = 328 nA) which reversed at –33 mV (reversal potential = –28.70 ± 1.64 mV, range –22 to –35 mV; n = 15) in accordance with the predicted chloride reversal potential (Taleb & Betz, 1994). Fitting of the data points from this oocyte with a single Hill equation yielded an EC50 of 0.28 µM and an nH of 0.41, representing a more than 5-fold increase in GABA sensitivity as compared to the low expression data set. At high expression levels, the spontaneous chloride current increased to over 200 nA (Fig. 1, filled triangles; 269 ± 61 nA, n = 15). The presence of a larger spontaneous current (200 nA) was concomitant with a further increase in overall GABA sensitivity (EC50 = 0.01 µM, nH = 0.53) and desensitization at GABA concentrations greater than the EC50 value (the group data for GABA EC50, nH and maximum values for the low, intermediate and high expression are given in Table 1). Collectively, the range of GABA EC50 values derived from different levels of expression ranged from 0.01 to 4.86 µM, with an nH of ~0.5–0.7 (n = 24).


Figure 1
View larger version (27K):
[in this window]
[in a new window]

 
Figure 1.  {alpha}6beta2{delta} receptors exhibit spontaneous activity and two separable state of agonist affinities
A, representative GABA current traces for high (top), intermediate (middle) and low (bottom) expression conditions with oocytes clamped at –70 mV. The dotted line indicates the zero-current level; the shaded area represents the spontaneous activity. The thick lines above the current traces represent the duration of GABA application. The duration of agonist application decreased with increasing concentration of agonist since the currents reached steady state (peaked) more rapidly at higher concentrations of agonist. B, plot of GABA concentration–response relationships including the spontaneous currents. All data were fitted with a single Hill equation. C, concentration–response relationship of the normalized GABA currents. The EC50, nH and maxima parameters for the group data for high, intermediate and low expression conditions are shown in Table 1. The continuous line shows the plot of the fit of a sum of two Hill equations to the data points from an oocyte with intermediate expression level demonstrating the presence of two components with different sensitivities to GABA. The dashed line shows the overall plot of the fit (group data) of sum of two Hill equations to the GABA concentration–response data points for the {alpha}6beta2{delta} receptor at median expression. D, a representative current trace for consecutive application of 0.03–20 µM picrotoxinin on an oocyte with high expression of {alpha}6beta2{delta} recptor. The thick lines below the current traces represent the duration of antagonist application. The arrow indicates the start of the picrotoxinin application at the concentration shown below it. E, the concentration–response relationship for picrotoxinin block of the spontaneous current form {alpha}6beta2{delta} receptor. Picrotoxinin inhibited greater than 90% of the spontaneous current with an IC50 of approximately 0.2 µM. F, the effect of 20 µM picrotoxinin application on the leak current (20 nA) from a mock-injected oocyte (see methods).

 

View this table:
[in this window]
[in a new window]

 
Table 1.  Parameters obtained from fitting the Hill equation to GABA, beta-alanine, taurine, I4AA, and 5{alpha}-THDOC data
 
The shallow slope of these concentration–response relationships suggests the presence of a mixture of receptor–channels with differing agonist sensitivities (Kuhse et al. 1993; Amin & Weiss, 1996). Refitting the data from the oocyte from the intermediate expression group (open circles) with the sum of two Hill equations suggested two distinct affinity components within the nanomolar and micromolar ranges (EC50 = 0.0052 µM, nH = 0.87, and GABA Imax = 124 nA for the high-affinity component, and EC50 = 1.54 µM, nH = 0.76, GABA Imax = 202 nA for the low-affinity component; Fig. 1C). The mean EC50 and nH parameters derived for the two components at the intermediate expression level are presented in Table 1 (see also dashed line in Fig. 1C). The high-affinity component displayed a 400-fold greater apparent affinity for GABA than the low-affinity component (EC50 values of 0.005 versus 2.29 µM). The relative magnitude of the two components (high to low affinity) was 0.54 (259.50 to 479.10 nA, see Table 1).

Reversal potential measurements indicate that a chloride conductance underlies the spontaneous current but do not demonstrate that the current is mediated by {alpha}6beta2{delta} receptors (since there are also endogenous chloride channels present within oocytes). Picrotoxinin, a specific pore blocker of GABAA receptors, was used to determine whether the spontaneous chloride current originates from {alpha}6beta2{delta} receptor expression. Figure 1D and E shows the picrotoxinin-induced current traces and concentration–response relationship from an oocyte expressing high levels of {alpha}6beta2{delta} receptor. Seven incremental concentrations of picrotoxinin (from 0.03 to 20 µM) were applied to oocytes expressing {alpha}6beta2{delta} subunits to construct a concentration–response relationship. Concentrations were applied incrementally because picrotoxinin possesses a high-affinity binding component for the {alpha}6beta2{delta} receptor that is resilient to complete wash out. Picrotoxinin blocked the spontaneous current arising from {alpha}6beta2{delta} receptors with both high efficacy and potency. The IC50 value for the picrotoxinin action was approximately 0.2 µM, with picrotoxinin, at 20 µM, blocking more than 90% of the spontaneous current (for all parameters, see Table 2). Figure 1F shows a control in which picrotoxinin is added to a mock-injected oocyte displaying 20 nA of leak current. Picrotoxinin (20 µM) did not attenuate the control leak current. These experiments demonstrate that the spontaneous current observed following expression of {alpha}6, beta2 and {delta} cRNAs originates from GABAA receptors.


View this table:
[in this window]
[in a new window]

 
Table 2.  Parameters obtained from fitting the Hill equation to data from Picrotoxinin-, Furosemide- and Zn2+-dependent block of the spontaneous current
 
GABAA antagonists block the spontaneous activity arising from {alpha}6beta2{delta} receptors

We examined the effects of several specific GABAA antagonists on the spontaneous current arising from {alpha}6beta2{delta} receptors. Among the antagonists tested, furosemide proved to be a specific antagonist for GABAA receptors containing the {alpha}6 subunit (Korpi et al. 1995; Korpi & Luddens, 1997). Furosemide was added at 2, 8, 20, 50, 200 and 500 µM concentrations to oocytes expressing {alpha}6beta2{delta} receptors. Figure 2A shows the corresponding current traces and the concentration–response relationship for inhibition of the spontaneous current. Furosemide inhibited 76% of the spontaneous current with an IC50 of 12.3 µM (see Table 2).


Figure 2
View larger version (22K):
[in this window]
[in a new window]

 
Figure 2.  Furosemide, bicuculline, gabazine and Zn2+ inhibit the spontaneous current arising from {alpha}6beta2{delta} receptors
A, furosemide blocked the spontaneous activity of {alpha}6beta2{delta} receptors. Current traces and the concentration–response relationship for furosemide-dependent inhibition of the spontaneous current arising from an oocyte with a high level of expression of {alpha}6beta2{delta} receptors. The dotted line indicates the zero-current level; the shaded area represents the spontaneous activity. The thick lines below the current traces represent the duration of antagonist application. B, bicuculline and gabazine inhibited the spontaneous activity of {alpha}6beta2{delta} receptors. Current traces representing bicuculline (5 µM) and gabazine (5 µM) inhibitory action on the spontaneous activity. C, the representative current traces and concentration–response relationship for Zn2+ block of the spontaneous current arising from {alpha}6beta2{delta} receptors.

 
Bicuculline and gabazine (SR95531) are specific competitive antagonists for GABAA receptors and 5 µM bicuculline or 5 µM gabazine blocked the GABA-independent component of the {alpha}6beta2{delta} receptors current by 48 ± 5% and 29 ± 5%, respectively (n = 4; Fig. 2B), demonstrating that competitive antagonists of GABAA receptors attenuate the spontaneous activity arising within {alpha}6beta2{delta} receptors.

Zinc inhibits GABAergic responses within neurons and is postulated to function as an endogenous modulator of ion channels in the CNS (Legendre & Westbrook, 1991; Smart, 1992; Dunne et al. 2002; Smart et al. 2004). We tested the effect of Zn2+ on the spontaneous current arising from {alpha}6beta2{delta} receptor expression. Figure 2C shows representative current traces and the concentration–response relationship of the Zn2+-mediated inhibition of the spontaneous current (IC50 of ~1.42 µM; Table 2).

Thus a range of established GABAA antagonists, including furosemide, bicuculline, gabazine, picrotoxinin and Zn2+ all inhibit spontaneous activity arising from the expression of {alpha}6beta2{delta} receptors.

Expression of a functional receptor–channel requires {alpha}6, beta2, and {delta} subunits

The presence of two components in the {alpha}6beta2{delta} GABA concentration–response relationship suggests the coexistence of at least two distinct and separable populations of ion channels. We tested the capacity of {alpha}6 and beta2, beta2 and {delta}, and {alpha}6 and {delta}, as well as that of beta2 alone to express ligand-gated ion channels by injecting these cRNA combinations into oocytes at quantities that yield a high level of expression for the {alpha}6beta2{delta} receptor (8–12 ng per oocyte). Four days post-injection, oocytes were tested for the presence of spontaneous activity and GABA-dependent activity using GABA concentrations of up to 500 µM. These subunit combinations yielded neither functional receptor–channels, nor a spontaneous current (n = 46). At significantly greater quantities of cRNA (20–30 ng per oocyte), beta2 or beta2 and {alpha}6 yielded receptor–channels which displayed spontaneous channel activity. However, the resulting beta2 or {alpha}6beta2 receptors exhibited a markedly reduced GABA maximal current (< 30 nA for beta2 n = 15 and < 150 nA for {alpha}6beta2 n = 30). Moreover, even at expression levels of 20–30 ng of cRNA per oocyte (~4-fold the quantities used for intermediate expression of {alpha}6beta2{delta}), neither beta2 nor {alpha}6beta2 receptors produced the magnitude of spontaneous current activity observed in {alpha}6beta2{delta} receptors (data not shown). Together these results suggest that neither the beta2 nor the {alpha}6beta2 receptors contribute significantly to the observed channel activity arising from the expression of {alpha}6beta2{delta} receptors.

Spontaneous channel activity is a unique property of the {alpha}6beta2{delta} receptor

Using the intermediate expression protocol (5–7 ng of cRNA), we tested expression of {alpha}1beta2{gamma}2S(Short), {alpha}1beta2{delta}, {alpha}4beta2{delta}, {alpha}6beta2{gamma}2S and {alpha}6beta2{delta} subunit combinations to determine if these receptors produced spontaneous channel activity. For each oocyte expressing a given subtype of GABAA receptor, we measured the magnitude of the spontaneous current as well as the GABA- and pentobarbital-induced maximal current 4 days post-injection. Figure 3A shows the background leak-subtracted magnitudes of spontaneous current for the aforementioned GABAA subunit combinations (see Methods and Table 3). The spontaneous current activity recorded from {alpha}6beta2{delta} receptors was significantly higher than that for any other GABAA receptors (ANOVA one-way analysis F ratio = 15.76; P < 0.001). Fisher's LSD multiple comparison test also showed that the magnitudes of spontaneous currents arising from {alpha}6beta2{delta} receptors were different from those of other GABAA receptors (P < 0.05). These experiments demonstrated that the significant level of spontaneous channel activity is a property unique to {alpha}6beta2{delta} receptors.


Figure 3
View larger version (12K):
[in this window]
[in a new window]

 
Figure 3.  Comparison of the spontaneous currents, GABA-induced maxima and pentobarbital relative maxima to GABA for {alpha}6beta2{delta}, {alpha}6beta2{gamma}, {alpha}4beta2{delta}, {alpha}1beta2{gamma}, and {alpha}1beta2{delta} receptors under equivalent expression conditions
A, comparison of the spontaneous currents for {alpha}6beta2{delta}, {alpha}6beta2{gamma}2, {alpha}4beta2{delta}, {alpha}1beta2{gamma}2 and {alpha}1beta2{delta} receptors under equivalent expression conditions. The {alpha}6beta2{delta} receptor exhibited a significantly higher spontaneous current than did the other GABAA receptors. B, comparison of the GABA-induced maximal current for {alpha}6beta2{delta}, {alpha}6beta2{gamma}2, {alpha}4beta2{delta}, {alpha}1beta2{gamma}2 and {alpha}1beta2{delta} receptors under equivalent expression conditions. GABA maximal current was determined from experiments in A using GABA concentrations 20–50 times the respective EC50 value. GABA had the lowest efficacy (maximal) for {alpha}6beta2{delta} receptors. C, comparison of the relative maximal current of pentobarbital to GABA for the GABAA receptor subtypes. Pentobarbital maximal current was determined from experiments in A using 1 mM concentration. Pentobarbital exhibited a significantly higher efficacy than did GABA for {alpha}6beta2{delta} receptors.

 

View this table:
[in this window]
[in a new window]

 
Table 3.  Spontaneous, GABA-induced (20–50x their relative EC50 values) and pentobarbital-evoked (1 mM) maximum currents (nA) for different GABAA receptor subtypes
 
GABA exhibits a low efficacy for {alpha}6beta2{delta} receptors

The maximal GABA-induced current for each subunit combination tested ({alpha}1beta2{gamma}2S, {alpha}1beta2{delta}, {alpha}4beta2{delta}, {alpha}6beta2{gamma}2S and {alpha}6beta2{delta}) was determined in the preceding experiments (where the spontaneous currents at intermediate expression levels were compared). GABA concentrations were used at 20–50 times the respective EC50 values (for EC50 values, see Table 1). A comparison of the maximal GABA-evoked currents for the five GABAA receptor subtypes is shown in Fig. 3B (for current values see Table 3). The maximal GABA-evoked current for {alpha}6beta2{delta} receptors was only 16–28% of that of the other subunit combinations tested. These data reveal that the GABA-sensitive component of {alpha}6beta2{delta} receptors is significantly smaller than that seen for other GABAA receptor subunit combinations. A comparison of the spontaneous current relative to the total current (maximal GABA-induced plus the spontaneous current) demonstrates that for {alpha}6beta2{delta} receptors the spontaneous activity represented approximately 23% of the total attainable current.

Pentobarbital, an intravenous anaesthetic, is a potent modulator of GABAA receptors and at high concentrations can directly activate them. Previous studies have shown that the GABA-dependent and pentobarbital-dependent activation domains are distinct, given that pentobarbital can activate a mutated GABAA receptor whose GABA-dependent activation domain is impaired (Amin & Weiss, 1993; Amin, 1999). We also determined the maximal pentobarbital-induced current for each GABAA receptor subtype within the preceding experiments at intermediate expression levels (on the same oocytes where the spontaneous activity and the GABA maxima were determined). Figure 3C shows the maximal current induced by 1 mM pentobarbital relative to that induced by GABA (pentobarbital Imax/GABA Imax x 100) for the GABAA receptor subtypes tested (see also Table 3). For all GABAA receptors tested, excepting {alpha}6beta2{delta} receptors, pentobarbital produced similar or lower maximal current than GABA. The pentobarbital-evoked maximal current was more than three times greater than that induced by GABA for {alpha}6beta2{delta} receptors and was similar in magnitude to the GABA maximal current for other GABAA receptors. Thus, pentobarbital is markedly more efficacious than GABA and acts as a full agonist for the {alpha}6beta2{delta} receptor when compared to GABA.

{alpha}6beta1{delta} and {alpha}6beta3{delta} receptors also exhibit the high-affinity state

Cerebellar granule neurons express high levels of {alpha}1, {gamma}2, {alpha}6, {delta}, beta2 and beta3 subunits in the adult rats (Laurie et al. 1992; Persohn et al. 1992; Wisden et al. 1996; Jechlinger et al. 1998). The {alpha}6 and {delta} subunits in combination with either beta1, beta2 or beta3 cRNAs (at intermediate expression levels) were coinjected into oocytes and the maximal GABA-induced current (100 µM) and the extent of the spontaneous activity for each receptor subtype was measured to determine whether the high-affinity state and the spontaneous activity of the {alpha}6beta2{delta} receptor depend upon the subtype of beta subunit (Fig. 4A). GABA induced a similar maximal current for {alpha}6beta1{delta}, {alpha}6beta2{delta} and {alpha}6beta3{delta} receptors. Further, all three {alpha}6beta1-3{delta} receptors displayed high levels of spontaneous activity, indicating the presence of the high-affinity state. The level of spontaneous activity was greater for {alpha}6beta1{delta} and {alpha}6beta3{delta} than for {alpha}6beta2{delta} receptors, suggesting that the {alpha}6beta1{delta} and {alpha}6beta3{delta} receptors may exhibit a higher propensity to assemble into the high-affinity state. Next, we determined a picrotoxinin concentration–response relationship (0.03–20 µM) to establish whether the spontaneous activity indeed arises from {alpha}6beta1{delta} and {alpha}6beta3{delta} receptors (Fig. 4B and C). Similar to the {alpha}6beta2{delta} receptor, picrotoxinin blocked the spontaneous current arising from {alpha}6beta1{delta} and {alpha}6beta3{delta} receptors with high potency (IC50 of ~0.3, see Table 2) and efficacy (~90% block at 20 µM). These experiments demonstrated that either the beta1, beta2 or beta3 subunit may coassemble with {alpha}6 and {delta} subunits to express spontaneously active receptor–channels in the high-affinity state.


Figure 4
View larger version (11K):
[in this window]
[in a new window]

 
Figure 4.  Expression of the high-affinity state of {alpha}6beta2{delta} receptors is independent of the isoform of the beta subunit
GABA induced similar maximal current for {alpha}6beta1{delta}, {alpha}6beta2{delta}, and {alpha}6beta3{delta} receptors (filled bars) with high levels of spontaneous activity indicating the presence of the high-affinity state (open bars). B and C, the concentration–response relationship for picrotoxinin block of the spontaneous current from {alpha}6beta1{delta} and {alpha}6beta3{delta} receptors.

 
Potency and efficacy of different GABA and glycine agonists upon {alpha}6beta2{delta} receptors

We compared the maximal induced current evoked by GABA with that of two other established GABA agonists, trans-4-aminocrotonic acid (TACA) and imidazole-4-acetic acid (I4AA), in the {alpha}6beta2{delta} receptor (at intermediate expression levels). Previous studies have established that TACA is a full agonist and I4AA as a partial agonist in GABAA receptors (Woodward et al. 1993; Chebib & Johnston, 1999; Mortensen et al. 2004). Figure 5A shows the maximal current induced by I4AA (1100 µM ~200 x EC50) and TACA (500 µM ~200 x EC50) relative to that of saturating concentrations of GABA (300 µM). For I4AA, the relative maximal current to that of evoked by GABA was 0.59 ± 0.06 (n = 9). In comparison, maximal currents evoked by TACA were consistently larger than that those evoked by GABA (1.22 ± 0.03, n = 5) demonstrating that for {alpha}6beta2{delta} receptors both GABA and I4AA behave as partial agonists relative to TACA.


Figure 5
View larger version (19K):
[in this window]
[in a new window]

 
Figure 5.  Comparison of the I4AA and TACA maximal-induced currents as well as beta-alanine and taurine concentration-response relationship for {alpha}6beta2{delta} receptors
A, comparison of the I4AA and TACA maximal-induced currents relative to GABA for {alpha}6beta2{delta} receptors. B, concentration–response relationship for I4AA and the fit of a sum of two Hill equations to these data points. The {alpha}6beta2{delta} receptors response to I4AA concentrations exhibited two components with marked difference in apparent affinity. C, the beta-alanine concentration–response relationships for oocytes with high ({blacktriangledown}), intermediate ({circ}) and low (bullet) {alpha}6beta2{delta} expression. The dashed line shows the plot of the fit (average from group data) of sum of two Hill equations to the beta-alanine concentration–response data point for wild-type {alpha}6beta2{delta} receptor at intermediate expression condition. D, taurine concentration–response relationships for {alpha}6beta2{delta} receptors at low (bullet), intermediate ({circ}), or high ({blacktriangledown}) expression condition. The dashed line shows the plot of the fit (average from group data) using a sum of two Hill equations to the taurine data points for the {alpha}6beta2{delta} receptor at intermediate expression condition.

 
A concentration–response relationship was constructed with 10 concentrations of I4AA, ranging from 0.001 to 4000 µM. Figure 5B depicts the fit of a sum of two Hill equations to these data points (under intermediate expression conditions). The response of {alpha}6beta2{delta} receptors to I4AA concentrations exhibited two components with a marked difference in their apparent affinity. For I4AA, the high- and the low-affinity components had EC50 values of 0.06 and 202.25 µM, respectively, translating into a 3400-fold difference in apparent affinity between the two components (Table 1). The relative maxima of the high- to the low-affinity components of the responses to I4AA was 1.39, as compared to 0.54 for GABA, suggesting that I4AA may have a significantly greater efficacy for the high-affinity state than for the low affinity state.

Both beta-alanine and taurine are classical glycine receptor agonists (Kuhse et al. 1993) and may act as neurotransmitters within the CNS. Using a range of beta-alanine concentrations from 0.05 to 10 000 µM, we determined the efficacy and potency of this agonist in oocytes expressing low, intermediate and high levels of {alpha}6beta2{delta} receptors (displaying 0, 70 and 190 nA of spontaneous current, respectively; Fig. 5C). For an oocyte with a low level of expression (filled circles), the EC50 for beta-alanine agonist was ~0.5 mM (the group data for beta-alanine are shown in Table 1). With increasing expression, the sensitivity of the {alpha}6beta2{delta} receptor to beta-alanine increased concomitantly with the high spontaneous activity (see open circles and filled triangles), reducing the EC50 value to approximately 1 µM (single fit to the Hill equation). The fit of the beta-alanine data from the {alpha}6beta2{delta} intermediate expression to the sum of two Hill equations yielded EC50 values of 1.16 and 594.66 µM, respectively, for the high and the low affinity components (see Table 1). A comparison of the overall GABA and beta-alanine maximal currents demonstrated that beta-alanine was as efficacious as GABA for {alpha}6beta2{delta} receptors (Imax beta-alanine at 10 000 µM/Imax GABA at 300 µM = 1.08 ± 0.03, n = 7).

Figure 5D shows taurine concentration–response relationships for three sets of oocytes with low (filled circles), intermediate (open circles) and high (filled triangles) levels of {alpha}6beta2{delta} expression (dispalying 40, 80 and 140 nA of spontaneous current, respectively; the group data for taurine are shown in Table 1). Fitting of the data points to the sum of two Hill equations yielded EC50 values of 5 and 807 µM for the high- and low-affinity components, respectively (Table 1). Taurine behaved as a partial agonist for {alpha}6beta2{delta} receptors as compared to GABA or beta-alanine. The relative efficacy of taurine (50 000 µM) to beta-alanine (10 000 µM) at near saturating concentrations was 0.69 ± 0.04 (n = 7).

The level of beta2 subunit expression determines the apparent affinity of {alpha}6beta2{delta} receptors

We injected the {alpha}6, beta2 and {delta} cRNA into oocytes in the ratios of 1{alpha}6 : 0.1beta2 : 1.8{delta}, 1{alpha}6 : 0.3beta2 : 1.8{delta}, or in the control 1{alpha}6 : 1beta2 : 1.8{delta}. The amount of injected cRNA was 5–7 ng of cRNA (intermediate expression) except for 1{alpha}6 : 0.1beta2 : 1.8{delta} where 8–12 ng (high expression) of cRNA was injected. A GABA concentration–response relationship was constructed as shown in Fig. 6A and B. At the 0.1beta2 ratio (1{alpha}6 : 0.1beta2 : 1.8{delta}; filled squares), the {alpha}6beta2{delta} receptors were predominantly present in the low-affinity state and displayed three notable properties: (1) the resulting {alpha}6beta2{delta} receptors were insensitive to GABA concentrations below 0.02 µM (EC50 of 1.3 µM; Table 1); (2) after removal of GABA, the current's return to baseline was satisfied by a fit to a single exponential; and (3) these receptor–channels showed no discernible spontaneous activity. With an increase in the beta2 ratio (0.3beta2, filled circles), GABA-induced currents were detected at concentrations as low as 0.002 µM (EC50 of ~1.5 µM; single fit, see Table 1). Moreover, the higher sensitivity to GABA was concomitant with an appearance of spontaneous channel activity (shaded area) and a shallower Hill coefficient than for the 0.1 beta2 ratio. Further, current decay, following agonist washout at higher concentrations followed a multiexponential decay (analysis not shown). At the control ratio of 1{alpha}6 : 1beta2 : 1.8{delta} (filled triangles), both high and low affinity components were readily discernible. The appearance of the high-affinity component thus coincided with a significant level of spontaneous channel activity with the current decay following removal of the agonist exhibiting a multiexponential paradigm. In experiments with the beta2 cRNA at a ratio 2–4 times higher (e.g. 1{alpha}6 : 2 or 4beta2 : 1.8{delta}; data not shown), the resulting {alpha}6beta2{delta} receptors were predominantly present in the high-affinity state, similar to that observed under condition of high expression (see also Fig. 1).


Figure 6
View larger version (23K):
[in this window]
[in a new window]

 
Figure 6.  The effect of change in beta2 subunit ratio on the expression of {alpha}6beta2{delta} and {alpha}1beta2{gamma}2 receptors
A, the current traces of receptor–channels from the expression of 1{alpha}6 : 0.1beta2 : 1.8{delta}, 1{alpha}6 : 0.3beta2 : 1.8{delta}, or control 1{alpha}6 : 1beta2 : 1.8{delta} ratios. The dotted line indicates the zero-current level; the shaded area represents the spontaneous activity. The thick lines above the current traces represent the duration of GABA application. B, the GABA concentration–response relationship for the three tested ratios of {alpha}6, beta2, and {delta} subunits. The data derived from 1{alpha}6 : 0.1beta2 : 1.8{delta} and 1{alpha}6 : 0.3beta2 : 1.8{delta} were fitted with a single Hill equation, while the data for 1{alpha}6 : 1beta2 : 1.8{delta} were fitted with a sum of two Hill equations. C, the concentration–response relationship for 1{alpha}1 : 0.08beta2 : 1.8{gamma}2S, 1{alpha}1 : 0.4beta2 : 1.8{gamma}2S and control1{alpha}1 : 1beta2 : 1.8{gamma}2S subunit combination.

 
The {alpha}1beta2{gamma}2S receptor is one of the most abundantly expressed GABAA receptor subtypes present within the CNS. To assess whether the marked change in GABA sensitivity brought on by altering the beta2 ratio is unique to {alpha}6beta2{delta} receptors, we repeated the preceding experiments, but varying the ratio of beta2 to {alpha}1 and {gamma}2S cRNA. We injected these cRNAs, in ratios of either 1{alpha}1 : 0.08beta2 : 1.8{gamma}2S, 1{alpha}1 : 0.4beta2 : 1.8{gamma}2S or the control ratio of 1{alpha}1 : 1beta2 : 1.8{gamma}2S into oocytes (intermediate expression condition) and determined GABA concentration–response relationships (Fig. 6C). For the 0.08beta2 (1{alpha}1 : 0.08beta2 : 1.8{gamma}2S; open squares), the EC50 and Hill coefficient parameters from a fit to a single Hill equation were 37.2 µM and 1.26, respectively (Table 1). These values were similar to those obtained from previous experiments with {alpha}1beta2{gamma}2S receptors in which the maximal GABA current was limited to ~1000 nA (for the range of maximal currents and EC50 values, see Table 1). At 0.4 beta2 (open circles) and at the control ratio (open triangles), the sensitivity of the resulting {alpha}1beta2{gamma}2S receptors increased by approximately 4- and 12-fold, respectively, in comparison to 0.08 beta2 with GABA maxima greater than 2 µA in magnitude (Table 1). Previous studies have shown that coinjection of cRNA for {alpha}1, beta2, and {gamma}2S also yields {alpha}1beta2 receptors which show an approximately 10-fold higher sensitivity to GABA than the {alpha}1beta2{gamma}2S receptor (Walters et al. 2000). The presence of {alpha}1beta2 receptors may contribute, in part, to the observed increase in GABA sensitivity of {alpha}1beta2{gamma}2S receptors. Nevertheless neither expression conditions for {alpha}1beta2{gamma}2S receptors resulted in the appearance of spontaneous channel activity.

With the increase in the ratio of beta2 cRNA, both {alpha}6beta2{delta} and {alpha}1beta2{gamma}2S receptors showed increases in their apparent affinity for GABA. However, the magnitude of the shift in GABA sensitivity to lower concentrations was 12-fold for the {alpha}1beta2{gamma}2S receptor in comparison to more than 400-fold for the {alpha}6beta2{delta} receptor. The increase in GABA sensitivity was concomitant with the appearance of spontaneous channel activity within the {alpha}6beta2{delta} receptor, but not for the {alpha}1beta2{gamma}2S receptor.

5{alpha}-THDOC directly activates {alpha}6beta2{delta} receptors

Neuroactive steroids are metabolites of the principal sex and stress steroid hormones and represent a large class of endogenous compounds active within the CNS (Belelli & Lambert, 2005). One such metabolite, 5{alpha}-THDOC, is a potent modulator of GABAA receptors (Puia et al. 1994), and is a highly hydrophobic compound that mediates its actions through a mechanism that is distinct from that of GABA binding (Morris & Amin, 2004). We examined the direct action of 5{alpha}-THDOC upon {alpha}6beta2{delta} receptors at a range of concentrations. Figure 7 shows 5{alpha}-THDOC-induced current traces and the concentration–response relationship for {alpha}6beta2{delta} receptors (at intermediate- and high-expression conditions). Concentrations as low as 30 nM of 5{alpha}-THDOC augmented the spontaneous current. For direct activation by 5{alpha}-THDOC, EC50 and nH values of 0.89 µM and 0.97 were derived, respectively (see Table 1). The 5{alpha}-THDOC-induced maximal current at 20 µM was similar in magnitude to that of GABA. Thus, 5{alpha}-THDOC, previously known for its modulatory action on GABAA receptors, can directly activate {alpha}6beta2{delta} receptors with high potency.